Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Amit L Jain"'
Autor:
Harsha Ranganath, Amit L. Jain, Justin R. Smith, Julie Ryder, Amina Chaudry, Emily Miller, Felicia Hare, Poojitha Valasareddy, Robert S. Seitz, David R. Hout, Matthew G. Varga, Brock L. Schweitzer, Tyler J. Nielsen, Janice Mullins, Douglas T. Ross, David R. Gandara, Gregory A. Vidal
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Immune checkpoint inhibitor (ICI) therapies represent a major advance in treating a variety of advanced-stage malignancies. Nevertheless, only a subset of patients benefit, even when selected based on approved biomarkers such as P
Externí odkaz:
https://doaj.org/article/ca410bdf72ce41f5b615b14aab591ed1
Autor:
Amit L. Jain, Janice Mullins, Justin R. Smith, Poojitha Valasareddy, Emily Miller, Amina Chaudhry, Julie Ryder, Felicia Hare, Harsha Ranganath, Michael Berry, David Robins, Lee Schwartzberg, Gregory A. Vidal
Publikováno v:
Journal of Medical Case Reports, Vol 14, Iss 1, Pp 1-7 (2020)
Abstract Background Papillary breast lesions may be benign, atypical, and malignant lesions. Pathological and clinical differentiation of breast papillomas can be a challenge. Unlike malignant lesions, benign breast papillomas are not classically ass
Externí odkaz:
https://doaj.org/article/f6097bd132984327b5e7cc566e5b412a
Autor:
David L. Saltman, Matthew G. Varga, Tyler J. Nielsen, Nicole S. Croteau, Heather M. Lockyer, Amit L. Jain, Gregory A. Vidal, David R. Hout, Brock L. Schweitzer, Robert S. Seitz, Douglas T. Ross, David R. Gandara
Publikováno v:
Clinical lung cancer.
Immune checkpoint inhibitors (ICI) are standard of care in advanced non-small cell lung cancer (NSCLC). However, not all patients benefit, even among PD-L1 tumor proportional score (TPS) ≥50%, indicating an unmet need for additional biomarkers such
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46b5e6b79875528b74f496ef67d2ed21
https://pubmed.ncbi.nlm.nih.gov/36564297
https://pubmed.ncbi.nlm.nih.gov/36564297
Publikováno v:
Anticancer Research. 40:5423-5426
BACKGROUND/AIM Exposure to pesticides has been reportedly associated with several types of cancer. MATERIALS AND METHODS In this study, we used data from The United States Geological Survey (USGS), United States Census, and the Surveillance, Epidemio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::276c09dcf9c35ec259d37d3caf585d10
https://doi.org/10.21873/anticanres.14552
https://doi.org/10.21873/anticanres.14552
Autor:
Mark Walker, Justin R. Smith, Gregory A. Vidal, Julie Ryder, Amit L Jain, Emily Miller, Omer Jamy, Poojitha Valasareddy, Edward J. Stepanski, Felicia Hare, Janice Nhan Mullins, Harsha Ranganath, Justin Gatwood, Rana Muhammad Usman, Lee S. Schwartzberg, Amina Chaudhry
Publikováno v:
Proc (Bayl Univ Med Cent)
The aim of this retrospective study was to assess the efficacy of topical hormonal therapy (THT) to relieve vaginal symptoms resulting from antihormonal therapy in women with hormone receptor–positive breast cancer. A total of 74 breast cancer pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5888429ea85cb97d94700d2d5d5f54c0
https://doi.org/10.1080/08998280.2020.1744059
https://doi.org/10.1080/08998280.2020.1744059
Autor:
Amit L Jain, Gregory A. Vidal, Felicia Hare, Janice Nhan Mullins, J Ryder, Amina Chaudhry, Poojitha Valasareddy, Harsha Ranganath
Publikováno v:
Cancer Research. 79:P5-11
Background: CDK4/6 inhibitor (CDKi) drugs are the current standard of care for treatment of first and second-line hormone-receptor positive/HER2 negative (HR+/HER2-) metastatic breast cancers. Numerous research efforts have commenced to understand bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3dafee4d637fb7d09920ea0cfe9ade6
https://doi.org/10.1158/1538-7445.sabcs18-p5-11-10
https://doi.org/10.1158/1538-7445.sabcs18-p5-11-10
Autor:
Terrence Jones, Victoria Beard, Sidharth Mahajan, Amit L Jain, Leonard Jefferson Harris, Emily McCollum Miller, Jim Wan, Patricia Goedecke, Gregory A. Vidal
Publikováno v:
Journal of Clinical Oncology. 40:e12502-e12502
e12502 Background: Adjuvant capecitabine (Cape) is standard of care for triple negative breast cancer (TNBC) cancer patients with residual disease following neoadjuvant chemotherapy. This is based on data from the CREATE-X study, which demonstrated a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d45f33aa475d3d4fe0471aab742def79
https://doi.org/10.1200/jco.2022.40.16_suppl.e12502
https://doi.org/10.1200/jco.2022.40.16_suppl.e12502
Publikováno v:
Cureus
Blastomyces dermatitidis is the causal agent of blastomycosis, an invasive and often serious fungal infection. Blastomycosis typically presents as a pulmonary infection, but common extrapulmonary manifestations of blastomycosis include the skin, bone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::288717d1e4b28e2ed0458e86cf2d585d
https://doi.org/10.7759/cureus.8508
https://doi.org/10.7759/cureus.8508
Autor:
D. Mi, T. Jones, Joanne Xiu, Y. Baca, J. Mullins, E.M. Miller, Amit L Jain, Rana Muhammad Usman, W.M. Korn, S. Cummings, Gregory A. Vidal, A. Chaudhry
Publikováno v:
Annals of Oncology. 32:S1229
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a9a233c1b160adecd8b54749398c1e8
https://doi.org/10.1016/j.annonc.2021.08.260
https://doi.org/10.1016/j.annonc.2021.08.260
Autor:
Rajanshu Verma, Amit L Jain, Rahul Peravali, Benedict Maliakkal, Satheesh Nair, Hemnishil K. Marella, Uchenna Agbim
Publikováno v:
Baylor University Medical Center Proceedings. 33:256-257
5-Fluorouracil (5-FU)–based chemotherapy is the most common regimen used to treat metastatic or advanced colon cancer. Neurotoxicity is a rare but serious adverse effect of 5-FU–based therapy. We report an unusual case of 5-FU–induced hyperammo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76b0cb7c6604ad64a3fb63e530e780f6
https://doi.org/10.1080/08998280.2019.1708689
https://doi.org/10.1080/08998280.2019.1708689